Discussion In this randomized controlled trial, supplementation with omega-3 FA (1 g of EPA + DHA per day) caused several nominally significant changes in ECG parameters over 2-years of follow-up.
← all excerpts
A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles.
2
—
—
The sentences
The P-wave amplitude also decreased in those assigned to placebo but remained stable in the EPA + DHA group; resulting in a borderline significant net change between groups (0.004 mV, 95% CI 0.000–0.007).